Search
forResearch 10 of 1000+
- Analysis of Female Pattern Hair loss
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Hepatic and renal impairment and degenerative changes caused by carbon black nanoparticles in mice
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- TREATMENT OF ACNE VULGARIS, OR EVERYTHING WE SHOULD KNOW ABOUT ISOTRETINOIN
- Assessing the burden of dermatological diseases on work life from a gender perspective
- The clinical features and long time follow-up of neonatal lupus erythematosus in 12 children
- Histopathological Correlates of NAFLD in PCOS: Correlation with Serum Creatinine, eGFR, and Urinary Albumin Levels
- CLINICAL AND LABORATORY STUDIES ON EMACIATION AND ILL-THRIFTINESS IN CATTLE AT ASWAN GOVERNORATE
Community 10 of 86
- Deciding Between Oral or Topical Min and Fin with Fatty Liver
- Increased liver enzymes from hairloss medications.
- Can liver problems be associated with response to the oral minoxidil?
- Sensitive liver, topical fin safe to try?
- Attention Finasteride / Dutasteride and Your liver
- liver problem from finasteride/dutasteride
- 28M: Can I Combine Oral and Topical Finasteride with Elevated Liver Enzymes?
- Could fatty liver(other issues related to it..)play a role in Dupa/Aga?
- ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’
- Finally live! alcohol-free, propylene glycol–free topical finasteride foam
Learn
— no results
Try a deeper search in learn →